Compare AU

Compare CURE vs. USD

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the BetaShares U.S. Dollar ETF (USD). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

USD

Popularity

Low

Low

Pearlers invested

80

4

Median incremental investment

$620.00

$1,978.27

Median investment frequency

Monthly

Monthly

Median total investment

$1,298.77

$1,019.85

Average age group

> 35

> 35


Key Summary

CURE

USD

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

USD.AX was created on 2011-01-31 by BetaShares. The fund's investment portfolio concentrates primarily on long usd, short aud currency. USD.AX aims to track the performance of the U.S. dollar against the Australian dollar (before fees and expenses). If the U.S. dollar goes up 10% against the A$ the Fund is designed to go up 10% too, before fees and expenses. Conversely, the Fund will go down if the U.S. dollar falls.

Top 3 holdings

AbbVie Inc (2.62 %)

Alnylam Pharmaceuticals Inc (2.59 %)

Amgen Inc (2.59 %)

AUD - AUSTRALIA DOLLAR (0.00 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Other (99.98 %)

Communication Services (0.00 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.45 %

0.45 %


Key Summary

CURE

USD

Issuer

Global X

BetaShares

Tracking index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.45 %

0.45 %

Price

$49.01

$15.69

Size

$34.191 million

$83.486 million

10Y return

N/A

24.33 %

Annual distribution yield (5Y)

4.24 %

1.74 %

Market

ASX

ASX

First listed date

12/11/2018

01/02/2011

Purchase fee

$6.50

$6.50


Community Stats

CURE

USD

Popularity

Low

Low

Pearlers invested

80

4

Median incremental investment

$620.00

$1,978.27

Median investment frequency

Monthly

Monthly

Median total investment

$1,298.77

$1,019.85

Average age group

> 35

> 35


Pros and Cons

CURE

USD

Pros

  • Higher exposure to US market

  • Higher distribution yield

  • Higher price growth

Cons

  • Lower price growth

  • Lower exposure to US market

  • Lower distribution yield

CURE

USD

Higher exposure to US market

Lower exposure to US market

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home